Haberland C, Martin H, Guski H, Hufnagl P, Vogel S
Institut für Pathologie, Universitätsklinikum Charité der Humboldt-Universität, Berlin.
Zentralbl Neurochir. 1996;57(1):5-11.
To evaluate the malignant potential of a tumor, data about its proliferative rate are essential. In this study clinical data, histological grading and immunohistochemical marker PCNA were applied on astrocytomas in childhood and were correlated to number, size and distribution of AgNORs. Tumor material from 90 patients, aged 1 to 15 years, was available. Histological grading, immunohistochemistry and AgNOR staining were performed on paraffin sections. PCNA-positivity was evaluated semiquantitatively. The AgNORs were quantified on 100 nuclei/case with an image analysis system. With aggravating malignancy we could show a shorter anamnesis, a lower survival and a higher PCNA-reactivity. We found a strong correlation between several AgNOR-features and the grade of malignancy of the astrocytomas, especially for the number of the AgNORs (from grade I: 1.73 AgNORs/nucleus to grade IV: 4.56 AgNORs/nucleus), the size of the AgNORs and its area amount of the nucleus. There were correlations between AgNOR-number and PCNA-reactivity as well as AgNOR-number and survival. Analysis of AgNORs, consequently, should provide prognostically relevant information helpful in more effective grading of astrocytomas.
为评估肿瘤的恶性潜能,有关其增殖率的数据至关重要。在本研究中,将临床数据、组织学分级和免疫组化标志物增殖细胞核抗原(PCNA)应用于儿童星形细胞瘤,并与核仁组成区嗜银蛋白(AgNORs)的数量、大小和分布进行关联分析。本研究获取了90例年龄在1至15岁患者的肿瘤组织。对石蜡切片进行组织学分级、免疫组化和AgNOR染色。对PCNA阳性进行半定量评估。使用图像分析系统对每个病例的100个细胞核中的AgNORs进行定量分析。随着恶性程度加重,我们发现患者的病史缩短、生存率降低以及PCNA反应性升高。我们发现多个AgNOR特征与星形细胞瘤的恶性程度之间存在强相关性,尤其是AgNORs的数量(从I级:1.73个AgNORs/细胞核到IV级:4.56个AgNORs/细胞核)、AgNORs的大小及其在细胞核中的面积占比。AgNOR数量与PCNA反应性以及AgNOR数量与生存率之间也存在相关性。因此,AgNORs分析应能提供有助于更有效分级星形细胞瘤的预后相关信息。